Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Chen, MD
Innolife Co., Ltd.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chongqing University 3 Gorges Hospital
Chongqing, China
Recruiting
- Ucla School of Medicine
Torrance, California, United States
Active, not recruiting - Innovative Research of West Florida, Inc.
Clearwater, Florida, United States
Completed - Universal Axon Clinical Research
Doral, Florida, United States
Withdrawn - Grady Clinical Research Center
Atlanta, Georgia, United States
Completed - Via Christi Research, A Division of Via Christi Hospitals Wichita, Inc.
Wichita, Kansas, United States
Withdrawn - Clinical Trials of America la, Llc
Monroe, Louisiana, United States
Withdrawn - St Louis Heart and Vascular
St Louis, Missouri, United States
Completed - Clinical Research of Gastonia
Gastonia, North Carolina, United States
Completed - Medication Management, Llc
Greensboro, North Carolina, United States
Withdrawn - Stern Cardiovascular
Germantown, Tennessee, United States
Withdrawn - Angiocardiac Care of Texas
Houston, Texas, United States
Completed - East Texas Cardiology
Houston, Texas, United States
Completed
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Jan 2020
- Primary completion
- 31 Dec 2022
- Completion
- 31 Jan 2023
- Last update posted
- 31 Mar 2022
- Registered enrollment
- 200
- Registry id
- NCT03875183
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.